Abstract:Cytoplasmic DNA triggers a danger signal response that has evolved to detect and eradicate infectious organisms. This year's Albert Lasker Basic Medical Research Award to Dr. Zhijian "James" Chen, Professor of Molecular Biology at UT Southwestern Medical Center, recognizes his contributions to determining the mechanism of how DNA is detected and the connection to the downstream signaling cascade that is essential for initiating an immune response. The field had established that DNA triggers proinflammatory IFN responses through the stimulator of IFN genes (STING) pathway ( 1 ) and its phosphorylation of IFN regulatory factor 3 (IRF3) — the transducer of IFN gene transcription ( 2 ). Prior studies showed that the multipass transmembrane STING protein functions as a direct innate immune sensor of bacterial elaborated cyclic diguanylate monophosphate (c-di-GMP) and cyclic diadenylate monophosphate (c-di-AMP) ( 3 ). Several DNA-sensing pattern-recognition receptors, including AIM2-related protein, IFI16, and DDX41, had previously been linked to STING activation. However, it was the Chen laboratory that discovered that the nucleotidyl transferase cyclic GMP-AMP synthase (cGAS) produces a second-messenger cyclic GMP-AMP (cGAMP) that binds to STING as the principal pathway inducing IFN (Figure 1) ( 4 , 5 ). Using a combination of mass spectrometry and protein purification strategies, cGAS was identified, and it was shown to bind to DNA and catalyze the synthesis ,of cGAMP from ATP and GTP. cGAMP binds to STING with high affinity, causing extensive ligand-induced conformational changes ( 6 ). cGAS/STING signaling and therapeutic targeting. ( A ) Activation of the cGAS/STING pathway can be triggered either through the importation of cGAMP or the presence of double-stranded DNA (dsDNA). Activated cyclic GMP-AMP synthase (cGAS) uses ATP and GTP to catalyze the formation of cGAMP that binds to STING localized on the ER membrane. STING then recruits TBK1, which activates/phosphorylates IRF3 and NF-κB, which translocates to the nucleus, thereby inducing the transcriptional activation of proinflammatory interferon responses. ( B ) A variety of therapeutics are being evaluated in clinical trials, such as cyclic dinucleotides or STING agonists that can trigger the activation of cGAS/STING pathway. The STING signal is terminated (denoted by the X) when activated STING in the ER-Golgi compartment binds to LC3 on the autophagy membrane, leading to the degradation of STING and the associated cytoplasmic DNA in the autolysosome. Excess intracellular cGAMP is transported out of the cell and hydrolyzed by ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) to yield AMP and GMP. ENPP1 inhibitors maintain proinflammatory cGAMP concentrations. ERGIC; endoplasmic-reticulum-Golgi intermediate compartment.

Hunting down the elusive cytosolic-DNA sensor

Sensing DNA as danger: The discovery of cGAS

2024 Lasker Award Recipient Zhijian Chen elucidates how DNA stimulates immunity

cGAS-cGAMP-STING: The three musketeers of cytosolic DNA sensing and signaling.

cGAS in action: Expanding roles in immunity and inflammation

Cellular functions of cGAS-STING signaling

DNA sensing by the cGAS–STING pathway in health and disease

cGAS is activated by DNA-induced oligomerization and has pivotal roles in antiviral defense and immune adjuvant effects

Cytosolic DNA sensing by cGAS: regulation, function, and human diseases

Discovery of Small Molecule Cyclic GMP-AMP Synthase Inhibitors.

Cgas-Sting: the Novel Mechanism of Cytosolic DNA Sensing Pathways

Progress in Functional Characterization of Cgas

Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase (cGAS), a Multifaceted Platform of Intracellular DNA Sensing

Structure of the Human cGAS–DNA Complex Reveals Enhanced Control of Immune Surveillance

ZCCHC3 is a co-sensor of cGAS for dsDNA recognition in innate immune response

Human Cgas Catalytic Domain Has an Additional DNA-binding Interface That Enhances Enzymatic Activity and Liquid-Phase Condensation.

New Frontiers on Intracellular cGAS Activation: Molecular Mechanisms, Cellular Signaling, and Therapeutic Strategies

Spatio-temporal analysis of the innate immune response to cytoplasmic dsDNA using a novel cGAMP biosensor

A microscopy reporter for cGAMP reveals rare cGAS activation following DNA damage, and a lack of correlation with micronuclear cGAS enrichment

The DNA Sensor cGAS is Decorated by Acetylation and Phosphorylation Modifications in the Context of Immune Signaling

Role of Post-Translational Modifications of cGAS in Innate Immunity